Inventor · disambiguated record
Susan Gregory
Also filed as: GREGORY SUSAN · GREGORY SUSAN A
17 granted patents·10 pending applications·778 citations·filing 1986–2012
95Inventor score
Top patents by PatentIndex Score
27 records- 0196US6136839ATreatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitorSEARLE & CO·Filed 1996·Granted Oct 24, 2000·356 cites·22 claims
- 0291US7507810B2Compositions and their uses directed to IL-4R alphaISIS PHARMACEUTICALS INC·Filed 2006·Granted Mar 24, 2009·14 cites·11 claims
- 0391US5990148ATreatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitorSEARLE & CO·Filed 1996·Granted Nov 23, 1999·95 cites·12 claims
- 0491US5700816ATreatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitorFiled 1995·Granted Dec 23, 1997·131 cites·21 claims
- 0589US6617345B1Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporinSEARLE & CO·Filed 2000·Granted Sep 9, 2003·35 cites·11 claims
- 0689US6407140B1Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitorSEARLE & CO·Filed 2000·Granted Jun 18, 2002·39 cites·20 claims
- 0777US6265439B1Halogenated phenylacetonitrile alkylaminoalkylphenyl compounds as immunosuppressivesSEARLE & CO·Filed 2000·Granted Jul 24, 2001·7 cites·22 claims
- 0875US7132441B2Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitorSEARLE & CO·Filed 2002·Granted Nov 7, 2006·9 cites·18 claims
- 0974US8765700B2Topical administrations of antisense compounds to VLA-4 for the treatment of respiratory conditionsTACHAS GEORGE·Filed 2005·Granted Jul 1, 2014·2 cites·14 claims
- 1074US5451604AHalogenated phenylacetonitrile alkylaminoalkylphenyl compounds as immunosuppressivesSEARLE & CO·Filed 1993·Granted Sep 19, 1995·11 cites·4 claims
- 1173US6342510B1Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitors and a leukotriene B4 receptor antagonistSEARLE & CO·Filed 1996·Granted Jan 29, 2002·32 cites·14 claims
- 1270US7141599B2Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporinPHARMACIA CORP·Filed 2003·Granted Nov 28, 2006·6 cites·4 claims
- 1369US4785077ASubstantially pure cytotoxicity triggering factorSCRIPPS CLINIC RES·Filed 1986·Granted Nov 15, 1988·15 cites·20 claims
- 1468US5247119APhenylacetonitrilehydroxyalkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressivesSEARLE & CO·Filed 1992·Granted Sep 21, 1993·10 cites·10 claims
- 1567US2009281169A1Compositions and Their Uses Directed to IL-4R AlphaISIS PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1657US8153603B2Compositions and their uses directed to IL-4R alphaKARRAS JAMES G·Filed 2006·Granted Apr 10, 2012·0 cites·20 claims
- 1755US6172096B1Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a leukotriene B4 receptor antagonistSEARLE & CO·Filed 1998·Granted Jan 9, 2001·10 cites·6 claims
- 1855US2005261228A1Antisense modulation of interleukin 12 P35 subunit expressionBENNETT C F·Filed 2005·Application pending·0 cites
- 1955US2005043355A1Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitorPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 2054US2012316221A1Compositions and their uses directed to il-4r alphaKARRAS JAMES G·Filed 2012·Application pending·0 cites
- 2152US2005182004A1Modulation of DC-SIGN expressionFiled 2004·Application pending·0 cites
- 2249US2003004191A1Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitorPHARMACIA CORP·Filed 2002·Application pending·0 cites
- 2346US6376528B1Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitorSEARLE & CO·Filed 1999·Granted Apr 23, 2002·6 cites·9 claims
- 2446US2007270366A1Double stranded nucleic acid molecules targeted to il-4 receptor alphaKARRAS JAMES G·Filed 2006·Application pending·0 cites
- 2546US2002107276A1Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene B4 receptor antagonistPHARMACIA CORP·Filed 2002·Application pending·0 cites
- 2645US2010056606A1Combination therapy using budesonide and antisense oligonucleotide targeted to IL4-receptor alphaISIS PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2734US2012088814A1Methods of modulating an immune response to a viral infectionGREGORY SUSAN·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Susan Gregory files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →